Wataru Hirose

6PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsRheumatology and arthritisAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 24, 2026
Efficacy of romosozumab as sequential therapy for bisphosphonates in glucocorticoid-induced osteoporosis.

|Mar 27, 2025
Safety and Efficacy of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE) for Mild COVID-19: A Double-Blind, Placebo-Controlled, Randomized Comparative Trial.

Hiroshi Odaguchi, Sumiko Hyuga, Mariko Sekine

|Jan 08, 2023
Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial.

Toshihiro Nanki, Mai Kawazoe, Kiyoko Uno

|Nov 21, 2022
Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis.

Wataru Hirose, Masayoshi Harigai, Koichi Amano

|Sep 01, 2021
Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis.

Wataru Hirose, Masayoshi Harigai, Koichi Amano

|Aug 27, 2021
Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study.

Sei Muraoka, Zento Yamada, Mai Kawazoe

Pageof 1

Frequent Collaborators

4 joint publications

Toshihiro Nanki

2 joint publications

Sei Muraoka

2 joint publications

Zento Yamada

2 joint publications

Hajime Kono